To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: Cancer is a complex disease characterized by the uncontrolled growth of abnormal cells, which can invade adjacent tissues and spread throughout the body. Hanahan and Weinberg proposed some common molecular signatures in cancer called Hallmarks. In 2011 inflammation was considered an important marker since the cells of the tumor microenvironment are supported by the infiltration of immune system cells. Neutrophils, observed in tumors since 1863 by Virchow, can be recruited by the tumor microenvironment and can favor the growth and tumor progression. Neutrophils present at the tumor site are called tumor-associated neutrophils (TAN) and can present different plasticities: N1 (antitumor) or N2 (pro-tumor). N1s have more cytotoxic activity for tumor cells, having increased amounts of pro-inflammatory factors such as CD95 (FAS), TNF-α, ICAM-1, and NOS2. N2s, on the other hand, have a more anti-inflammatory profile, exhibiting higher levels of arginase-1, CCL2, VEGF, IL-8, and MMP-9, supporting tumor growth. Our study group pioneered in polarizing, in vitro, human neutrophils to the N2-like phenotype and investigating the role of pro-tumor neutrophils in tumor cell growth. We have observed over the years that some pharmacological strategies are capable of decreasing the number of N2-like neutrophils in vitro, but increasing the polarization of neutrophils to an N1-like phenotype would be interesting to understand how these neutrophils can kill tumor cells in a controlled environment. MATERIAL AND METHODS: Neutrophils were isolated in a ficoll gradient from the peripheral blood of healthy donors (CAAE 65372522.4.0000.5257) and were treated with LPS and IFNγ for 3 h at 37°C and 5% CO2. We first observed by flow cytometry a marker more expressed in N1 neutrophils, CD95 after 3h. We used two invasive tumor cell lines, MDA-MB-231 (breast cancer) and U87-MG (glioblastoma), for the other assays. Viability assays (MTT) of tumor cells treated with N1-like neutrophils were performed for 20h, in addition to investigating the production of ROS (intracellular probe DCF, 1h kinetics) by neutrophils when co-cultured with tumor cells. RESULTS AND CONCLUSION: Neutrophils polarized for 3 h with LPS and IFNγ showed more positive events for CD95 than N0 (naive) neutrophils, indicating polarization to an N1-like phenotype. When tumor cells were treated with these neutrophils for 20 h, their viability was reduced by approximately 50% compared to cells not treated with neutrophils, indicating that our N1-like can decrease the viability of the tumor cells. We also observed that N1-like neutrophils in contact with MDA-MB-231 tumor cells were able to increase the production of total ROS after 20 min, when compared to naive neutrophils. Our results suggest that we are facing a new polarization of N1-like neutrophils, highly capable of combating MDA-MB- 231 and U87-MG tumor cells in vitro, which may become a promising model for cancer therapy.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper